Real-time enrollment status for this recurrent acute lymphoblastic leukemia clinical trial
Current Status
Recruiting
Checked: September 6, 2026 at 5:41 AM UTC
| NCT Number | NCT03136146 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Acute Lymphoblastic Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 42 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | August 10, 2026 (3 weeks ago) |
As of September 6, 2026: Clinical trial NCT03136146 is currently recruiting participants. This phase2 study for recurrent acute lymphoblastic leukemia is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03136146 is actively recruiting participants as of September 6, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03136146 was last updated 3 weeks ago (August 10, 2026). HelloStudys verifies this status automatically.